| 6ANL: reference: Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 MAP kinase inhibitors., Kaieda A, Takahashi M, Takai T, Goto M, Miyazaki T, Hori Y, Unno S, Kawamoto T, Tanaka T, Itono S, Takagi T, Hamada T, Shirasaki M, Okada K, Snell G, Bragstad K, Sang BC, Uchikawa O, Miwatashi S, Bioorg Med Chem. 2017 Dec 24. pii: S0968-0896(17)31781-9. doi:, 10.1016/j.bmc.2017.12.031. PMID: 29291937 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).